Table 1.
Gender | Age | |||||||
---|---|---|---|---|---|---|---|---|
Diagnosis group | Nb | Male | Female | NA | Mean | Median | ||
Exploratory cohort | Colorectal cancer | Stage IV | 50 | 25 (50%) | 25 (50%) | – | 65 | 65 |
Healthy | 76 | 48 (63%) | 28 (37%) | – | 51 | 53 | ||
Confirmation cohort | Colorectal cancer | All stages | 791 | 452 (57%) | 331 (42%) | 8 (1%) | 70 | 70 |
Stages 0/I/II | 425 | 252 (59.3%) | 172 (40.5%) | 1 (0.2%) | 72 | 72 | ||
Stage III | 180 | 108 (60%) | 72 (40%) | – | 70 | 71 | ||
Stage IV | 186 | 92 (49%) | 87 (47%) | 7 (4%) | 65 | 66 | ||
Breast cancer | Stages II or III | 169 | – | 169 (100%) | – | 49 | 48 | |
Other cancers | HCC | 18 | 18 (100%) | – | – | 62 | 64 | |
Pancreatic | 3 | 2 (67%) | 1 (33%) | – | 78 | 78 | ||
Ovarian | 1 | – | 1 (100%) | – | 44 | 44 | ||
Lymphoma | 1 | 1 (100%) | – | – | 69 | 69 | ||
Total | 23 | 21 (91%) | 2 (9%) | – | 63 | 66 | ||
All cancers | 983 | 473 (48.1%) | 502 (51.1%) | 8 (0.8%) | 66 | 67 | ||
Healthy | 289 | 179 (62%) | 110 (38%) | – | 43 | 46 |
a, Nb: number; b, NA: not available; c, HCC: Hepatocellular carcinoma.